Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novosis leuprorelin implant versus Enantone Monats-Depot in prostate cancer
2008-000926-38Phase 3Active
- Sponsor
- Novosis
- Start
- Mar 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of leuprolide in prostate cancer (PCa) (2 arms), sponsored by Novosis. Primary endpoints: Testosterone AUC through Day 56 and Proportion reaching castration testosterone level. Started Mar 2008; status: active.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-000926-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000926-38.